21852902 2024-11-01 2025-10-31 21852902 2024-11-01 2025-10-31 1 21852902 2024-11-01 2025-10-31 1 21852902 2024-11-01 2025-10-31 2 21852902 2024-11-01 2025-10-31 3 21852902 2024-11-01 2025-10-31 1 21852902 2022-11-01 2023-10-31 21852902 2021-11-01 2022-10-31 21852902 2020-11-01 2021-10-31 21852902 2023-10-31 21852902 2022-10-31 21852902 2021-10-31 21852902 2024-11-01 2025-10-31 Hovedtal Investeret kapital 21852902 2023-11-01 2024-10-31 Hovedtal Investeret kapital 21852902 2022-11-01 2023-10-31 Hovedtal Investeret kapital 21852902 2021-11-01 2022-10-31 Hovedtal Investeret kapital 21852902 2020-11-01 2021-10-31 Hovedtal Investeret kapital 21852902 2023-11-01 2024-10-31 21852902 2025-10-31 21852902 2024-10-31 21852902 2024-11-01 c:ContributedCapitalMember 21852902 2024-11-01 c:RetainedEarningsMember 21852902 2024-11-01 2025-10-31 c:RetainedEarningsMember 21852902 2025-10-31 c:ContributedCapitalMember 21852902 2025-10-31 c:RetainedEarningsMember 21852902 2023-11-01 2024-10-31 1 21852902 2024-11-01 c:GoodwillMember 21852902 2025-10-31 c:GoodwillMember 21852902 2024-11-01 2025-10-31 c:GoodwillMember 21852902 2024-11-01 c:LandAndBuildingsMember 21852902 2024-11-01 c:FixturesFittingsToolsAndEquipmentMember 21852902 2024-11-01 c:PropertyPlantAndEquipmentInProgressAndPrepaymentsForPropertyPlantAndEquipmentMember 21852902 2024-11-01 2025-10-31 c:LandAndBuildingsMember 21852902 2024-11-01 2025-10-31 c:FixturesFittingsToolsAndEquipmentMember 21852902 2024-11-01 2025-10-31 c:PropertyPlantAndEquipmentInProgressAndPrepaymentsForPropertyPlantAndEquipmentMember 21852902 2025-10-31 c:LandAndBuildingsMember 21852902 2025-10-31 c:FixturesFittingsToolsAndEquipmentMember 21852902 2025-10-31 c:PropertyPlantAndEquipmentInProgressAndPrepaymentsForPropertyPlantAndEquipmentMember iso4217:DKK xbrli:pure 2026-04-28 BDO Statsautoriseret Revisionspartnerselskab Havneholmen 2, 6. sal DK-2450 Copenhagen SV 45719375 2026-04-28 Ieva Blekte Tackie Årsrapport Agilent Technologies Denmark ApS Produktionsvej 42 2600 Glostrup Den uafhængige revisors erklæring 21852902 1999-07-01 Glostrup 2024-11-01 2025-10-31 2023-11-01 2024-10-31 BDO Statsautoriseret Revisionspartnerselskab Havneholmen 2, 6. sal 2450 Copenhagen SV Today the Board of Directors and Executive Board have discussed and approved the Annual Report of Agilent Technologies Denmark ApS for the fi­nan­ci­al year 1 November 2024  - 31 October 2025. The Annual Report is presented in accor­dance with the Da­nish Fi­nan­ci­al State­ments Act. In our opinion the Fi­nan­ci­al Sta­te­ments give a true and fair view of the Company's assets, liabilities and financial position at 31 October 2025 and of the results of the Company's operations for the fi­nan­ci­al year 1 November 2024  - 31 October 2025. The Management Commentary includes in our opinion a fair presentation of the matters dealt with in the Commentary. We recommend the Annual Report be approved at the Annual General Meeting. Copenhagen 2026-04-28 Anders Meier Anders Meier Chairman Ieva Blekte Tackie Kasper Ib Schiermer Jørgensen To the Shareholder of Agilent Technologies Denmark ApS Konklusion We ha­ve au­di­ted the Fi­nan­ci­al Sta­te­ments of Agilent Technologies Denmark ApS for the fi­nan­ci­al year 1 November 2024 - 31 October 2025, which comprise income statement, Balance Sheet, sta­te­ment of chan­ges in e­qui­ty, no­tes and a summary of significant accounting policies. The Fi­nan­ci­al Sta­te­ments are pre­pared in accordance with the Da­nish Fi­nan­ci­al State­ments Act.   In our o­pi­ni­on, the Fi­nan­ci­al Sta­te­ments give a true and fair view of the assets, liabilities and financial position of the Com­pa­ny at 31 October 2025 and of the results of the Com­pa­ny's operations for the fi­nan­ci­al year 1 November 2024 - 31 October 2025 in accordance with the Da­nish Fi­nan­ci­al State­ments Act.   Basis for OpinionGrundlag for konklusion We conducted our audit in accordance with International Standards on Auditing (ISAs) and the additional requirements applicable in Denmark. Our responsibilities under those standards and requirements are further described in the “Auditor’s Responsibilities for the Audit of the Fi­nan­ci­al Sta­te­ments” section of our report. We are independent of the Com­pa­ny in accordance with the International Ethics Standards Board for Accountants’ International Code of Ethics for Professional Accountants (including International Independence Standards) (IESBA Code), together with the ethical requirements that are relevant to our audit of the Financial Statements in Denmark, and we have fulfilled our other ethical responsibilities in accordance with these requirements and the IESBA Code. We be­lie­ve that the e­vi­den­ce we ha­ve ob­tai­ned is suf­fi­ci­ent and ap­prop­ria­te to pro­vi­de a ba­sis for our con­clu­si­on.   Grundlag for konklusion Ma­na­ge­ment's Re­spon­si­bi­li­ti­es for the Fi­nan­ci­al Sta­te­ments Management is responsible for the preparation of Fi­nan­ci­al Sta­te­ments that give a true and fair view in accordance with the Da­nish Fi­nan­ci­al State­ments Act and for such Internal control as Ma­na­ge­ment determines is necessary to enable the preparation of Fi­nan­ci­al Sta­te­ments that are free from material misstatement, whether due to fraud or error.   In preparing the Fi­nan­ci­al Sta­te­ments, Ma­na­ge­ment is responsible for assessing the Com­pa­ny's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting in preparing the Fi­nan­ci­al Sta­te­ments unless Management either intends to liquidate the Com­pa­ny or to cease operations, or has no realistic alternative but to do so.   Our objectives are to obtain reasonable assurance about whether the Fi­nan­ci­al Sta­te­ments as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor’s report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs and the additional requirements applicable in Denmark will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these Fi­nan­ci­al Sta­te­ments.   As part of an audit conducted in accordance with ISAs and the additional requirements applicable in Denmark, we exercise professional judgment and maintain professional skepticism throughout the audit. We also:   Identify and assess the risks of material misstatement of the Fi­nan­ci­al Sta­te­ments, whether due to fraud or error, design and perform audit procedures responsive to those risks, and obtain audit evidence that is sufficient and appropriate to provide a basis for our opinion. The risk of not detecting a material misstatement resulting from fraud is higher than for one resulting from error as fraud may involve collusion, forgery, intentional omissions, misrepresentations, or the override of internal control.   Obtain an understanding of internal control relevant to the audit in order to design audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Com­pa­ny's internal control.   Evaluate the appropriateness of accounting policies used and the reasonableness of accounting estimates and related disclosures made by Ma­na­ge­ment.   Conclude on the appropriateness of Ma­na­ge­ment’s use of the going concern basis of accounting in preparing the Fi­nan­ci­al Sta­te­ments and, based on the audit evidence obtained, whether a material uncertainty exists related to events or conditions that may cast significant doubt on the Com­pa­ny's ability to continue as a going concern. If we conclude that a material uncertainty exists, we are required to draw attention in our auditor’s report to the related disclosures in the Fi­nan­ci­al Sta­te­ments or, if such disclosures are inadequate, to modify our opinion. Our conclusions are based on the audit evidence obtained up to the date of our auditor’s report. However, future events or conditions may cause the Com­pa­ny to cease to continue as a going concern.   Evaluate the overall presentation, structure and contents of the Fi­nan­ci­al Sta­te­ments, including the disclosures, and whether the Fi­nan­ci­al Sta­te­ments represent the underlying transactions and events in a manner that gives a true and fair view.   We communicate with those charged with governance regarding, among other matters, the planned scope and timing of the audit and significant audit findings, including any significant deficiencies in internal control that we identify during our audit.   Statement on Management Commentary Management is responsible for Ma­na­ge­ment Com­men­ta­ry.   Our opinion on the Fi­nan­ci­al Sta­te­ments does not cover Ma­na­ge­ment Com­men­ta­ry, and we do not express any form of assurance conclusion thereon.   In connection with our audit of the Fi­nan­ci­al Sta­te­ments, our responsibility is to read Ma­na­ge­ment Com­men­ta­ry and, in doing so, consider whether Ma­na­ge­ment Com­men­ta­ry is materially inconsistent with the Fi­nan­ci­al Sta­te­ments or our knowledge obtained during the audit, or otherwise appears to be materially misstated.   Moreover, it is our responsibility to consider whether Ma­na­ge­ment Com­men­ta­ry provides the information required under the Danish Financial Statements Act.   Based on the work we have performed, we conclude that Ma­na­ge­ment Com­men­ta­ry is in accordance with the Fi­nan­ci­al Sta­te­ments and has been prepared in accordance with the requirements of the Danish Financial Statements Act. We did not identify any material misstatement of Ma­na­ge­ment Com­men­ta­ry.   Copenhagen 2026-04-28 BDO Statsautoriseret Revisionspartnerselskab 45719375 Ole C. K. Nielsen Den uafhængige revisors erklæring State Authorised Public Accountant mne23299 956183000 964729000 1062728000 132500000 144480000 116860000 33119000 48648000 46079000 -562000 -1401000 -5400000 20718000 32466000 27037000 848308000 797672000 842273000 592873000 572155000 539689000 500803000 504762000 592873000 572430000 486432000 Invested capital Invested capital Invested capital Invested capital Invested capital -69588000 -59798000 -29200000 -35593000 -20349000 11.4 18.4 8.9 12.8 6.6 74.3 75.3 69.9 71.7 64.1 3.6 9.8 3.6 5.8 5.1 The ratios follow in all material respects the recommendations of the Danish Finance Society.  The ratios stated in the list of key figures and ratios have been calculated as follows:   Invested capital: Intangible fixed assets (ex goodwill) + tangible assets + inventories + receivables + other working current assets – trade payables – other provisions – other long and short term working liabilities Return on invested capital: Profit/loss on ordinary activities x 100          Average invested capital Equity ratio:  Equity, at year end x 100Total equity and liabilities, at year end Return on equity: Profit/loss after tax x 100        Average equity Principal activities Agilent Technologies Denmark ApS, hereinafter referred to as “company”, operates as a reseller of products/services covering life sciences, diagnostics and applied chemicals markets. A major part of the products/services range is purchased from group companies within and outside of Denmark. The company is also engaged in the business of rendering contract manufacturing, research & development, product marketing and administrative services to group companies outside of Denmark. There is no significant change in the company’s activities or financial and economic conditions. Development in activities and financial and economic position The Agilent group continued to make progress in its transformational journey that started with the new leadership team assuming charge in the preceding year. It announced a new organizational structure to align Agilent’s businesses according to its end markets and customers. The company is focused on improving operational efficiency through process realignment and ongoing development, while also exploring new products, markets, and business opportunities across the group. In the past year, the company witnessed difficult macroeconomic and industry specific disruptions. The company was exposed to persistent inflationary conditions exerting pressures on operational efficiencies. The company implemented measures including cost effectiveness, customer centricity and process simplifications to achieve sustainable profitable growth. The company continues to invest in capacity expansion, and it is reflected in the surge in work in progress fixed assets and accounts payable balances towards year end. Performance for the year compared to the expected development In 2025, the company realized total sales of DKK 1,018 M compared to DKK 1,025 M in 2024. The result for the year is a Profit of DKK 24 M as compared to DKK 61 M in 2024. The total sales of DKK 1,018 M are in line with management's prior estimate of DKK 900M–1,100M from the previous year. The profits of DKK 24 M are lower than management’s prior estimate of DKK 40-60 M from the previous year. During the year, the company faced economic volatility and persistent inflation that placed sustained pressure on operational efficiencies. Notwithstanding these challenges, the Agilent group continues to respond with discipline, advancing its strategic initiatives and transformation efforts to remain resilient amid evolving market and geopolitical dynamics. Significant events after the end of the financial year Apart from the developments noted above, the management is not aware of any event after 31st October 2025 that may have a material impact on the company’s financial position. Financial risk Risk Management The company acts as reseller of Agilent products/services to customers. The company also performs contractual services in operations, research and marketing to internal Agilent partners. The company carries risks which are generally associated with these functions and takes appropriate risk management measures. Key Business Risks The regulatory environment The company is subject to a range of requirements in the countries in which it operates. The company is focused on complying with these regulations and is dedicated to having a constructive and collaborative dialogue with the authorities.   Market conditions The company sells to customers who get reimbursement from public authorities. Reductions in these reimbursements may impact its consolidated sales and cash flow. The competitive environment is expected to be stable with high entry barriers. Financial risks The financial risk factors primarily comprise foreign exchange, and credit risks. The company’s financial risk management is based on policies approved by the Board of Directors. The company may use derivatives to hedge financial risks. Hedging of financial risks is managed at management level and is only focused on managing risks arising from the company’s operations and financing. Foreign exchange risk Foreign exchange risks occur due to imbalance between income and expenses in each foreign currency. Credit risk The company’s credit risk primarily relates to receivables, securities, cash and cash equivalents, and positive fair values of derivative financial instruments. The balance sheet valuation of all the items mentioned corresponds to the size of the maximum credit risk. The company has historically not experienced any material loss on receivables, as most customers are public hospitals or laboratories.  Counterparty risks concerning cash and cash equivalents and financial instruments are managed by only entering into agreements with financial institutions which have achieved a satisfactory rating from recognized international credit-rating institutions. Liquidity risk Liquidity risk is the risk that the company will not be able to meet its financial obligations as they fall due. The company’s approach to managing liquidity is to ensure, as far as possible, that it will always have enough liquidity to meet its liabilities as they fall due, under both normal and stressed conditions, without incurring unacceptable losses or risking damage to the company’s reputation. Research and development activities The company’s operations include providing contractual research, development and marketing services to other intra group entities. The company’s knowledge resources are the employee relationships with professionals who bring specialized technical and market knowledge in diagnostics and allied areas. These activities only generate service revenues for the company and any other knowledge asset which may get generated would be exclusively owned by the recipient of the services. The company maintains continued focus in developing new products and improving the existing portfolio.   Future expectations The management recognizes the challenges of the current economic environment but expects a profitable fiscal ahead. The corporate guidance for worldwide Agilent group earnings is publicly available in our first quarter earnings report released on 25th Feb 2026. It is Agilent’s group policy to release estimates of future earnings at a consolidated worldwide level. With respect to the Denmark based company the revenues are estimated to be in a broad range from DKK 900M to 1,100M based on past business trends. The Agilent group expects that market conditions will continue to be challenging and possibly also be affected by increasing uncertainties in global supply chains and tariff concerns. Consequently, the net profits are broadly estimated to be in the range of DKK 20-60M. Corporate social responsibility (CSR) report Agilent Technologies group is committed to conducting business in an ethical, socially responsible and environmentally sustainable manner. Our Citizenship Objective is to be an economic, intellectual and social asset to each nation and community in which we operate. Agilent's Community Relations and Giving Programs and the Agilent Foundation are tangible examples of our commitment to exemplary Corporate Citizenship.  - Environmental matters, including the company's activities to reduce the climate impact of activities. Agilent group is also committed to achieving net-zero greenhouse gas emissions no later than 2050. Our progress on this goal is independently validated by the Science Based Targets initiative and verified annually by S&P Global Sustainable 1. After releasing our Net Zero goals, Agilent group has installed solar capacity on our large sites and generated over 6MWh of renewable energy and installed more efficient lighting and system controls. As part of our “Design for the Environment initiative, we've created award-winning products that use less energy, water and space. This includes Intuvo 9000 GC which uses less than half the electrical power of a conventional instrument. Our 4210MP-AES atomic spectrometer now runs on air instead of combustible gases. Likewise, our scroll pumps now use oil-free technology and refurbishing services that reduce waste and encourage reuse   Agilent group operates an EHS management system designed to minimize adverse environmental and occupational health and safety impacts and ensure ongoing compliance with external regulations and internal EHS standards, while meeting the needs of key stakeholders. Our EHSMS is aligned to ISO 14001 and ISO 45001 and covers our design, development, manufacturing, and sourcing activities worldwide. Our EHS policy commits to maintaining healthy, safe, and environmentally responsible workplaces, aiming for operations that keep employees free from injury and illness. It ensures all activities, products, and services comply with environmental, health, and safety requirements while driving continuous improvement in sustainability through recycling, waste reduction, resource conservation, pollution prevention, and climate impact mitigation. Managers and employees are trained and held accountable for preventing workplace injuries, supported by wellness programs that enhance overall well being and productivity. The company also engages suppliers and contractors to follow aligned EHS principles and performance expectations. This policy is approved by executive leadership and applies to all Agilent operations worldwide. Agilent group operates a highly effective Certified Pre-Owned Instruments program which contributes to a more circular and sustainable economy. It also includes a Trade In and Buy back program together with a refurbished parts and instruments program. On a global level, Agilent refurbished around 5,000 instruments which can be saved from being disposed in landfills. Agilent is also increasing the number of instruments carrying “My Green Lab Accountability, Consistency, and Transparency (ACT) Label. The label indicates the environmental footprint of our products, information. Our ACT-certified products now account for around 40% of Agilent’s global instrument revenues.  - Social and staff matters Agilent is certified as a Great Place to Work by the Great Place to Work Institute in multiple countries in the world based on independent surveys. At Agilent, our policy is that our culture provides a strong work environment for our teams, empowers individuals to be high performers, and supports the outstanding results that the company delivers. Our rewards and retention programs have ensured that more than one-third of all our open positions are filled up internal employees as promotions or job rotations. Agilent's dedication to diversity and inclusion has had a positive impact on our workplace, innovation, and business outcomes. We have strong processes in recruiting, training & development, retention, performance management to ensure committed human resources. The company together with our employee volunteers operate several social and educational programs in partnership with local communities and academia to promote the study of mathematics and sciences among women, summer camps in junior schools. All employees of the Agilent group are entitled to six days of paid volunteer time off annually; in the past year employees spent over 54,000 hours in socially beneficial causes across the world. The Agilent Foundation together with its employee volunteers work with reputed charities like UNHCR, The Nature Conservancy and Doctors Without Borders. The Foundation together with participating employees contributed around USD 4 Million in various philanthropic activities. Agilent group also operate programs like LGBTQ, Council of Black Employees and Veterans@Agilent to promote various social causes. The company conducted employee events like “International Women’s Day”, “Danmarks Mentale Sundhedsdag” and several recreational events covering “Kunstforeningen”, golfing etc. to ensure employee wellbeing. The company also participated in social causes like blood donation visits with “Den mobile blodbank and supporting sustainability and recycling on “Jordens Day”. These efforts have demonstrated the company’s commitment to social responsibility and good citizenship in the local kommunes. They have promoted employee engagement and motivation. The company intends to continue and further invest in these initiatives in FY26 and beyond. - Matters relating to human rights Agilent affirms its commitment to the Universal Declaration of Human Rights and integrates integrity and ethical conduct into its corporate culture. The company prohibits forced labor, including slavery and human trafficking, ensuring all employment is freely chosen. It rejects child labor, complying with all minimum age laws and refusing to exploit children in any form. Agilent guarantees fair wages, benefits, and legally compliant working hours, along with protected leaves for all employees. Its policies forbid discrimination and promote diversity across characteristics such as race, gender, sexual orientation, religion, disability, and national origin. Agilent ensures a safe and healthy workplace, banning violence, harassment, and threats, while also respecting employees’ rights to freedom of association and collective bargaining. The company requires ethical business conduct from employees and mandates that its suppliers uphold the same human rights standards worldwide. Agilent requires employees to report any suspected violations of its Standards of Business Conduct, supported by a global Compliance Helpline and an Open Door Policy for confidential or anonymous reporting. The company conducts supplier due diligence on globally managed suppliers and selected indirect suppliers to identify and mitigate risks, including modern slavery. Agilent trains procurement staff to strengthen awareness of human rights risks in supply chains. In FY25, Agilent used a third party SaaS platform to evaluate over 600 suppliers on Human Rights, Labor, and ESG criteria. The company also uses an independent auditor to assess supplier compliance with its Supplier Code of Conduct. When issues arise, corrective actions are implemented and monitored by Agilent’s third-party auditor DEKRA, with all FY25 actions completed as planned. Agilent reports no identified operations or suppliers with significant risk of modern slavery incidents. We are committed to sourcing components and materials from organizations that share our values, and do not knowingly conduct business with any individual or company that participates in the exploitation of children, physical punishment, forced labor, or human trafficking. The efforts include providing disclosures pursuant to the above law, imparting training to employees in procurement functions, ensure our suppliers adhere to the requirements of the Act and take remedial and punitive actions where necessary. Agilent requires that suppliers ensure that material supplied to Agilent are DR of Congo Conflict Free. Further, Agilent routinely requests and reviews the suppliers’ Conflict Minerals Reporting.  Template (CMRT) Agilent - Anti-corruption and bribery We consider the risk of corruption and bribery in our market to be low. Agilent’s Global Anti Corruption Policy requires all employees, leaders, and third party representatives to act with uncompromising integrity, prohibiting any exchange of value intended to gain business advantages, including bribes, kickbacks, or quid pro quos. The company must maintain accurate financial records, enforce strong internal controls, and conduct thorough due diligence on external partners to prevent and detect corruption. Agilent also bans facilitating payments except in extremely rare situations involving immediate threats of physical harm, and any such incident must be reported and documented. Employees are obligated to report suspected misconduct through management, Legal, or the Compliance Hotline, with protection against retaliation for good faith reporting. Violations of anti corruption laws can lead to severe civil and criminal penalties for both Agilent and individuals, including fines, imprisonment, and termination of employment. Managers are responsible for promoting awareness, ensuring compliance, and may be held accountable for violations within their teams. Employees and agents must complete required training, certify compliance, and cooperate fully with investigations. Agilent emphasizes that no employee will face negative consequences for refusing to engage in corrupt behavior, even if it results in lost business. Agilent group’s suppliers are expected to comply with all applicable (global and local) anti-corruption laws, rules, and regulations, including the U.S. Foreign Corrupt Practices Act, the UK Bribery Act and those enacted under the OECD Convention on Combating Bribery of Foreign Public Officials in International Business Transactions. Agilent Technologies Denmark ApS has not identified any breach during both FY24 and FY25, and management expects the same for coming year. As the expectation is to maintain the positive results are zero breaches, the work under the policy is expected to remain unchanged from prior years.   Policy for data ethics The company is aligned with the Agilent group’s policies, standards and operating procedures around data ethics which can be publicly accessed at; https://www.agilent.com/home/privacy-policy    It recognizes the importance of data protection and privacy. It is committed to acting in accord with the values, particularly those of Uncompromising Integrity and Accountability, in handling personal data and being a responsible data steward and a trusted partner in this digital and global business environment. It treats the collection of data according to the applicable laws, and in line with its privacy principles of respecting individual rights, acting with transparency, and embedding privacy in its designs. Report of target figures and policies for the under-represented gender Gender distribution within Management                                2024/25 Number of members of the supreme management body                                                 3 Under-represented gender, share in % of the supreme management body                                                33% Number of people at other management levels                                        9 Under-represented gender, share in % at other management levels                                    50%  Of the total number of members of the Company's supreme management body, the under-represented gender comprises 33% which meet the criterion for equal distribution of men and women. Hence, the Company is not subject to the obligation of setting a target figure for the gender distribution of the supreme management body. Target figures for other management levels                                                                                       2024/25 Target figures in % for the other management levels                                                                                45% Year, in which the target figures are expected to be met                                                                        2030 Policy for other management levels      • Currently, five of our nine local functional departments within are headed by women leaders, this corresponds to about 50% of our departmental management positions in the company. The company is also committed to Dansk Industri pledge to achieve a 40/60 split by 2030. This is aligned with the overall Agilent commitments around Diversity and Inclusiveness which includes metrics around global gender pay equity and representation of women in leadership. The policies prohibit discrimination based on race, color, age, gender, sexual orientation, gender identity and expression, ethnicity, religion, disability, veteran status, national origin or any protected class.      • The company takes a position that a diverse organization is value-adding and contributes to the achievement of overall business goals. It is therefore a policy to encourage a balanced gender distribution at all management levels by:      • Securing that filling of all management positions, whether facilitated by HR or external consultants, is done by assessment of the collective skill set of each candidate independent of gender.      • Requiring that external search consultants engaged for recruitment for management positions propose a reasonable number of candidates of each gender.      • Having succession planning practices in place requiring managers to identify a gender-diverse range of potential successors for critical management positions.      • Requiring managers to discuss with qualified subordinates of the under-represented gender as part of their recurrent performance review how and if advancement to a (higher) management position could be relevant and what potentially would be required.      • Regularly obtaining qualitative data regarding the background for the gender distribution at various management levels both from a potential candidate perspective and from an employer perspective. 1018130000 1025827000 879908000 850999000 138222000 174828000 50098000 43039000 49759000 49808000 28000 83000 38393000 82064000 3973000 6391000 5935000 3914000 36431000 84541000 12339000 23161000 24092000 61380000 0 18907000 0 18907000 292087000 293287000 55085000 47675000 90390000 62250000 437562000 403212000 437562000 422119000 3370000 5866000 3370000 5866000 55746000 45602000 205816000 173722000 1167000 129000 293000 0 263022000 219453000 209062000 221375000 475454000 446694000 913016000 868813000 5000000 5000000 673345000 649253000 678345000 654253000 6909000 4949000 1870000 1512000 8779000 6461000 68605000 46850000 19495000 36677000 4730000 14810000 36059000 31471000 225892000 208099000 225892000 208099000 913016000 868813000 DKK '000Sha­re ca­pi­talRetained profitTotal Equity at 1 November 20245.000649.253654.253 Proposed profit allocation, see note 7 24.09224.092 Equity at 31 October 20255.000673.345678.345 At 1st November 2016 the share capital was raised by 1 share at a value of 1 DKK. 5000000 649253000 24092000 5000000 673345000 1 | Net revenue Segment details (geography) EMEA270.138273.332 Americas8.55112.983 APAC739.439739.512 1.018.1281.025.827 Segment details (activities) Cross lab148.156137.761 Diagnostics and Genomics44.96453.075 Life sciences and applied market group825.008834.991 1.018.1281.025.827 2 | Staff costs Ave­ra­ge num­ber of full ti­me em­ploy­ees724719 Wages and salaries 546.286530.497 Pensions 47.22544.083 Social security costs 6.9806.224 Other staff costs 11.7849.252 612.275590.056 Remuneration of Management and Board of Directors 4.8214.872 4.8214.872 In accordance to section 98 B (3) of the Danish Financial Statements Act, renumeration to the Executive Board has not been disclosed. 724 719 546286000 530497000 47225000 44083000 6980000 6224000 11784000 9252000 612275000 590056000 4821000 4872000 3 | Fee to statutory auditor Total fees: BDO 375360 375360 Specification of fees: Statutory audit 293280 Assurance engagements 4280 Other services 400 375360 293000 280000 42000 80000 40000 0 4 | Financial income Other financial income 3.9736.391 3.9736.391 3973000 6391000 3973000 6391000 5 | Financial expenses Other financial expenses 5.9353.913 5.9353.913 5935000 3913000 5935000 3913000 10379000 20846000 0 60000 1960000 2255000 7 | Proposed distribution of profit Retained earnings 24.09261.380 24.09261.380 24092000 61380000 24092000 61380000 8 | Intangible assets DKK '000Goodwill Cost at 1 November 2024 194.113Cost at 31 October 2025 194.113  Amortisation at 1 November 2024 175.206Amortisation for the year 18.907Amortisation at 31 October 2025 194.113 Carrying amount at 31 October 20250 DKK '000Goodwill Cost at 1 November 2024 194.113Cost at 31 October 2025 194.113  Amortisation at 1 November 2024 175.206Amortisation for the year 18.907Amortisation at 31 October 2025 194.113 Carrying amount at 31 October 20250 194113000 194113000 175206000 18907000 194113000 0 9 | Property, plant and equipment DKK '000Land and buildingsOther plants, machinery, tools and equipmentTangible fixed assets in progress and prepayment Cost at 1 November 2024 362.924107.08462.250 Additions 16.38125.06728.140 Disposals 0-9230 Cost at 31 October 2025 379.305131.22890.390   Depreciation and impairment losses at 1 November 2024 69.63759.4090 Reversal of depreciation of assets disposed of 0-880 Depreciation for the year 17.58117.615 Depreciation and impairment losses at 31 October 2025 87.21876.1440 Carrying amount at 31 October 2025292.08755.08490.390   362924000 107084000 62250000 16381000 25067000 28140000 0 923000 0 379305000 131228000 90390000 69637000 59409000 0 0 880000 17581000 17615000 87218000 76144000 0 292087000 55084000 90390000 20252024 DKK '000DKK '000 10 | Prepayments and accrued income Costs 2930 2930 11 | Provision for deferred tax Provision for deferred tax comprises deferred tax on intangible and tangible fixed assets and privisions. 20252024 DKK '000DKK '000 Deferred tax constitues: Tangible fixed assets -10.502-5.285 Debt accruals 3.593336 -6.909-4.949 Deferred tax, beginning of year -4.949-2.694 Deferred tax of the year, income statement -1.960-2.255 Provision for deferred tax 31 October-6.909-4.949 12 | Other provisions for liabilities 0-1 år 1.8701.512 Warranties are included in other provisions with TDKK 1,870 (23/24: TDKK 1,512). 13 | Accruals and deferred income Deferred income mainly relates to prepaid service contracts. 4492000 9275000 15 | Related parties The Controlling interest The company is wholly owned subsidiary of Agilent Technologies Luxco LLC with registered office at Corporation Trust Center, 1209 Orange Street, Wilmington, New Castle County, Delaware, 19801, USA. The ultimate parent company in which the company is included as a subsidiary is Agilent Technologies Inc. Thiscompany and its subsidiaries are considered as related parties. Other related parties having performed transactions with the company The company’s related parties having a significant influence comprise subsidiaries and associates as well as the companies’ Board of Directors, Board of Executives and executive officers and their relatives. Related parties include also companies in which the above mentioned group of persons has material interests. 16 | Consolidated Financial Statements The accounts of Agilent Technologies Luxco LLC can be obtained by request to the Company, and the accounts of Agilent Technologies Inc. Santa Clara, USA can be obtained by request to Agilent Technologies Denmark ApS, Denmark.   The Annual Report of Agilent Technologies Denmark ApS for 2024/25 has been presented in accor­dance with the pro­vi­sions of the Da­nish lar­ge-si­ze Fi­nan­ci­al State­ments Act for en­ter­pri­ses in re­por­ting class C.  Regnskabsklasse C, stor virksomhed1trueThe Annual Report is prepared consistently with the accounting principles applied last year.   Regnskabsklasse C, stor virksomhed true Net revenue Net revenue from sale of merchandise and finished goods is recognised in the Income Statement if supply and risk transfer to purchaser has taken place before the end of the year and if the income can be measured reliably and is expected to be received. Net revenue is recognised exclusive of VAT, duties and less discounts related to the sale.   Where products with a high degree of individual adjustments are delivered, recognition in net revenue is made as and when the production progresses, the net revenue being equal to the sales value of the work performed for the year (the production method). This method is applied when the total costs and expenses regarding the contract and the degree of completion at the balance sheet date can be reliably assessed, and it is likely that the financial benefits will flow to the company.    Production costs Production costs comprise costs, including wages and salaries and write-off, incurred to achieve the net revenue for the year. This includes direct and indirect costs of raw materials and consumables, wages and salaries, rent and leasing and depreciation of production plant.   Distribution costs The costs incurred for distribution of goods sold during the year and for sales campaigns carried out during the year are recognised in distribution costs. The costs of the sales personnel, advertising and exhibition costs and amortisation are also recognised in distribution costs.   Administrative expenses Administrative expenses recognise costs incurred during the year regarding management and administration of the group, inclusive of costs relating to the administrative staff, executives, office premises, office expenses, etc. and related amortisation.   Other operating income Other operating income includes items of a secondary nature in relation to the Group’s and the Company’s activities. In addition, profit from sale of intangible and tangible fixed assets as well as business interruption and conflict compensations are included. Compensations are recognised when the income is deemed to be realisable.   Financial income and expenses Financial income and expenses include interest income and expenses, financial expenses of finance leases, realised and unrealised gains and losses arising from investments in financial assets, debt and transactions in foreign curren­cies, amortisation of financial assets and liabi­lities as well as charges and allowances under the tax-on-account scheme etc. Financial income and expenses are recognised in the income statement by the amounts that relate to the financial year.   Tax The tax for the year, which consists of the current tax for the year and changes in deferred tax, is recognised in the income statement by the portion that may be attributed to the profit for the year, and is recognised directly in the equity by the portion that may be attributed to entries directly to the equity.   Intangible fixed assets Acquired goodwill is measured at cost less accumulated amortisation. Goodwill is amortised on a straight-line basis over the expected useful life which is estimated to 10 years. The period of amortisation is determined based on an assessment of the acquired company’s position in the market and earnings profile, and the industry-specific conditions.   Property, plant and equipment Other plant, fixtures and equipment are measured at cost less accumulated depreciation and impairment losses. Land is not depreciated.   The depreciation base is cost less estimated residual value after end of useful life.   The cost includes the acquisition price and costs incurred directly in connection with the acqui­sition until the time when the asset is ready to be used. As regards self-manufactured assets, the cost price includes cost of materials, components, subcontractors, direct payroll and indirect production costs.   Straight-line depreciation is provided on the basis of an assessment of the expected useful lives of the assets and their residual value:   Useful lifeOther plant, fixtures and equipment 3-20 år0 % Profit or loss on sale of property, plant and equipment is stated as the difference between the sales price less selling costs and the carrying amount at the date of sale. Profit or loss is recognised in the Income Statement as other operating income or other operating expenses.   Impairment of fixed assets The carrying amount of in­tan­gib­le fi­xed and pro­per­ty, plant and equip­ment are valued on an annual basis for indications of impairment other than that reflected by amortisation and depreciation.    In the event of impairment indications, an impairment test is made for each asset or group of assets, respectively. If the net realisable value is lower than the carrying amount, the assets are written down to the lower value.   The recoverable amount is calculated at the higher of net selling price and capital value. The capital value is determined as the fair value of the expected net cash flows from the use of the asset or group of assets and the expected net cash flows from sale of the asset or group of assets after the end of its useful life.    Inventories Inventory is valued at standard cost, which approximates actual cost computed on a first-in, first-out basis, not in excess of market value. We assess the valuation of our inventory on a periodic basis and make adjustments to the value for estimated excess and obsolete inventory based on estimates about future demand.   Receivables Receivables are measured at amortised cost which usually corresponds to nominal value. The value is reduced by impairment losses to meet expected losses.   Write-off is performed to provide for losses when an objective indication has been assessed to have incurred that a receivable or a portfolio of receivables are impaired. If there is an objective indication that an individual receivable is impaired, the write-off is performed at individual level.   Receivables for which there are no objective indication of impairment at individual level are assessed at portfolio level for objective indication of impairment. The portfolios are primarily based on the debtors’ registered office and credit rating in accordance with the Company’s policy for credit risk management. The objective indicators, which are applied for portfolios, are determined based on the historical loss experiences.   Write-off is determined as the difference between the carrying amount of receivables and the present value of the expected cash flows, including realisable value of any received collaterals. The effective interest rate is used as discount rate for the single receivable or portfolio.   Accruals, assets Accruals recognised as assets include costs incur­red relating to the subsequent financial year.   Other provisions for liabilities Provisions for liabilities include the expected cost of warranty commitments and pension.   Warranty commitments include liabilities for improvement of work within the warranty period of 1 year. The provision for liabilities is measured and recognised on the basis of experience with warranty work. Pension commitments: To the extent that the pension commitments are not covered by insurance, they are included in the balance sheet as provisions. The calculation of the liability is based on actuarial computations.   Tax payable and deferred tax Current tax liabilities and receivable current tax are recognised in the balance sheet as the calculated tax on the taxable income for the year, ad­justed for tax on the taxable income for previous years and taxes paid on account.   The Company is subject to joint taxation with Danish group companies. The current corporation tax is distributed among the joint taxable companies in proportion to their taxable income and with full allocation and refund related to tax losses. The joint taxable companies are included in the on account tax scheme. Joint taxation contributions receivable and payable are recognised in the Balance Sheet under current assets and liabilities, respectively.    Deferred tax is measured on the temporary dif­ferences between the carrying amount and the tax value of assets and liabilities.   Deferred tax assets, including the tax value of tax loss carry-forwards, are measured at the ex­pected realisable value of the asset, either by set-off against tax on future earnings or by set-off against deferred tax liabilities within the same legal tax entity.   Deferred tax is measured on the basis of the tax rules and tax rates that under the legislation in force on the balance sheet date will be ap­pli­cable when the deferred tax is expected to crystallise as current tax. Any changes in the deferred tax resulting from changes in tax rates, are recognised in the income statement, except from items recognised directly in equity.   Liabilities Financial liabilities are recognised at the time of borrowing by the amount of proceeds received less borrowing costs. In subsequent periods, the financial liabilities are measured at amortised cost equal to the capitalised value when using the effective interest, the difference between the proceeds and the nominal value being recog­nised in the Income Statement over the term of loan.   Amortised cost for short-term liabilities usually corresponds to the nominal value.   Accruals, liabilities Accruals recognised as liabilities include payments received regarding income in subsequent years.   Foreign currency translation Transactions in foreign currencies are translated using “Average monthly rate” for the month in which the transaction is recorded. This average rate is derived from and closely represents the actual exchange rates in force during that month. Exchange differences arising between the “Average monthly rate” and the rate on the payment date are recognized in the Income Statement as financial income or expense. Accounts receivable, payable and other monetary items in foreign currencies that are not settled on the balance sheet date are translated at the exchange rate on the balance sheet date. The difference between the exchange rate on the balance sheet date and the exchange rate at the time of occurrence of the receivable or payable is recognised in the income statement as financial income or expenses. Fixed Assets acquired in foreign currencies are translated using “Average monthly rate” as described above for the month in which the transaction is recorded.   Cash Flow Statement   With reference to Section 86(4) of the Danish Financial Statements Act, the company has not prepared a cash flow statement. A cash flow statement has been prepared for the Group.   With reference to Section 86(4) of the Danish Financial Statements Act, the company has not prepared a cash flow statement. A cash flow statement has been prepared for the Group.